Reasons associated with treatment non-adherence in schizophrenia in a Pakistan cohort

被引:18
作者
Ahmad, Irshad [1 ]
Khalily, Muhammad Tahir [1 ]
Hallahan, Brian [2 ]
机构
[1] Int Islamic Univ, Dept Psychol, Islamabad, Pakistan
[2] Natl Univ Ireland, Dept Psychiat, Galway, Ireland
关键词
Pharmacotherapy; Psychotic relapse; Schizophrenia; Treatment non-adherence; MENTAL-HEALTH NURSES; ANTIPSYCHOTIC MEDICATION; 1ST EPISODE; ADHERENCE; NONCOMPLIANCE; INTERVENTION; PSYCHOSIS; RELAPSE; FAMILY; PREDICTORS;
D O I
10.1016/j.ajp.2017.07.024
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Treatment: non-adherence in patients with schizophrenia is the most common reason for a relapse of psychosis. In a cohort of participants in Pakistan who suffered a relapse of psychosis, we aimed to identify the principal factors associated with non-adherence, including any culture specific factors that might not be as significant in other jurisdictions. Semi-structured interviews were undertaken at four psychiatric hospitals in the Peshawar region in Pakistan with 55 participants (44 male and 11 female) diagnosed with schizophrenia, who had suffered a relapse of psychosis subsequent to treatment non-adherence. The five principal documented reasons for treatment non-adherence were: 1) alternative treatment pathway chosen with a traditional faith healers (n = 53, 96.4%), 2) lack of insight (n = 36, 65.5%), 3) poor economic status (n = 33, 60.0%), 4) adverse effects of medications (n = 33, 60.0%) and 5) utilising psycho-active substances as an alternative to psychotropic medications (n = 27, 41.1%). A number of identified factors associated with a relapse of psychosis are potentially modifiable including the provision of a range of pharmacological options including second generation antipsychotic agents, long acting injectable antipsychotics and psycho-therapeutic interventions including psychoeducation. These interventions should prove cost effective and be associated with reduced relapse rates of psychosis.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 47 条
  • [11] Problems with non-adherence to antipsychotic medication in Samoan new Zealanders: A literature review
    Ioasa-Martin, Itagia
    Moore, Laurie Jo
    [J]. INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2012, 21 (04) : 386 - 392
  • [12] Koran reading and negotiation with jinn: strategies to deal with mental ill health among Swedish Somalis
    Johnsdotter, Sara
    Ingvarsdotter, Karin
    Ostman, Margareta
    Carlbom, Aje
    [J]. MENTAL HEALTH RELIGION & CULTURE, 2011, 14 (08) : 741 - 755
  • [13] Kane J. M., 2006, J CLIN PSYCHIAT, V68, P27
  • [14] THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) FOR SCHIZOPHRENIA
    KAY, SR
    FISZBEIN, A
    OPLER, LA
    [J]. SCHIZOPHRENIA BULLETIN, 1987, 13 (02) : 261 - 276
  • [15] Kazadi NJB, 2008, SAJP-S AFR J PSYCHI, V14, P52
  • [16] Drug affordability and prescription noncompliance in the United States: 1997-2002
    Kennedy, J
    Coyne, J
    Sclar, D
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (04) : 607 - 614
  • [17] Khalifa N., 2011, International Journal of Culture and Mental Health, V4, P68, DOI DOI 10.1080/17542863.2010.503051
  • [18] Costs of schizophrenia
    Knapp, M
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 509 - 518
  • [19] Life expectancy and cardiovascular mortality in persons with schizophrenia
    Laursen, Thomas M.
    Munk-Olsen, Trine
    Vestergaard, Mogens
    [J]. CURRENT OPINION IN PSYCHIATRY, 2012, 25 (02) : 83 - 88
  • [20] Family education for people with schizophrenia in Beijing, China - Randomised controlled trial
    Li, Z
    Arthur, D
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 : 339 - 345